A Pilot, 3-arm Randomized Controlled Trial of a Fruit and Vegetable Prescription Program for Patients With Type Two Diabetes
Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of servings each day. F\&V prescription (F\&V Rx) programs are embedded into clinical settings and provide patients with vouchers to purchase F\&V at local retailers. The proposed study aims to test the effects of a F\&V Rx on diabetes self-management education and support (DSME/S) uptake and retention, dietary intake of F\&V and diet quality, glucose control (hemoglobin A1c), and program implementation outcomes.
• Patient at Penn State Health St. Joe's Medical Center
• Diagnosis of Type 2 Diabetes Mellitus greater than or equal to six months
• A1c level is greater than or equal to 7% (53 mmol/mol)
• Low income defined as enrolled in Supplemental Nutrition Assistance Program (SNAP), is uninsured or have Medicaid, or identifying as food insecure based on USDA criteria.
• Ability to give a blood sample
• Willing to respond to contacts from study staff over the study period
• Willing and able to give informed consent
• Can read and write in English or Spanish